http://www.eyegatepharma.com
EyeGate Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
EyeGate Pharmaceuticals, Inc. Headquaters
271 Waverley Oaks Road
Waltham,02452
United States
EyeGate Pharmaceuticals, Inc. Share price
17 May 2023 13:10 GMT
$0
0.0 (0 %)
EyeGate Pharmaceuticals, Inc. Market cap
$
WMC RANKING
2024
EyeGate Pharmaceuticals, Inc. # 367
BiotechnologyLatest EyeGate Pharmaceuticals, Inc. News
12 Feb 2024
Uveitis Treatment Market Size to Surpass USD 2.6 Billion by 2032 | Exhibiting CAGR of 4.6%
The global uveitis treatment market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032,...
12 Feb 2024
Le marché des médicaments contre le cancer du sein devrait connaître une croissance incroyable d'ici 2030 | Roche ...
Roche Group, Novartis, Pfizer, Bristol-Myers Squibb, Puma Biotech, Verzenio (Eli Lilly), HALAVEN (Eisai Inc), AstraZeneca, GlaxoSmithKline,...
12 Feb 2024
Uveitis Treatment Market Size to Surpass USD 2.6 Billion by 2032 | Exhibiting CAGR of 4.6%
The global uveitis treatment market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032,...
WMC Market Score
WMC Market to Revenue Score
EyeGate Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| EyeGate Pharmaceuticals, Inc. | USD | $12 | $8,835 | $-8,721 | $ 0.00 | 367 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total EyeGate Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
EyeGate Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
EyeGate Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
EyeGate Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
EyeGate Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| EyeGate Pharmaceuticals, Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
